vimarsana.com

Latest Breaking News On - Shizuoka cancer center - Page 1 : vimarsana.com

No Benefit Seen With Adjuvant Nivolumab in Gastric/GEJ Cancer

Adding nivolumab to adjuvant chemotherapy did not improve relapse-free survival in a phase 3 trial of patients with gastric/GEJ cancer.

No Benefit Seen With Adjuvant Nivolumab in Gastric/GEJ Cancer

Adding nivolumab to adjuvant chemotherapy did not improve relapse-free survival in a phase 3 trial of patients with gastric/GEJ cancer.

Roundup: India s CoWIN to track all vax status and more briefs

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.